In This Issue of Psychiatric Times: Vol 37, No 2
February 28, 2020
Read the Psychiatric Times February 2020 issue cover-to-cover, with a bonus PDF.
Recent Content
An Underutilized Option for Bipolar Depression
February 28, 2020
When we find ourselves in the half-tested world of off-label therapies, what’s a psychiatrist to do?
Demographic Insights in Alcohol-Related Deaths
February 27, 2020
Over the past two decades, deaths associated with alcohol abuse have increased, but little data point to demographic changes.
Psychiatry Comic: Identity Crisis
February 27, 2020
My hacker stole my identity crisis.
Surprising Benefits of the Expansion of Coverage Under the Affordable Care Act
February 27, 2020
Access to care has improved—especially for low-income and vulnerable populations—which has resulted in better health outcomes.
The New Year Brings Good News, Bad News
February 26, 2020
Drug companies are investing more to study psychiatric disorders, and there may be novel treatments in the near future.
The Non-Binary Story and the Rescue of Self: Healing Stories of the Third Kind
February 26, 2020
A hypothetical first conversation with a non-binary person . . . One of us would be feeling nervous and the other certain—a phenomenon not unfamiliar to a psychiatrist, only here the roles would be reversed.
The Show Must Go On
February 25, 2020
A phone rings on stage like a flashback and we return to our fantasy that characters can die and revive, that the show must go on . . .
Buprenorphine Treatment for Opioid Use Disorder
February 25, 2020
Although 6 months is the recommended duration for buprenorphine treatment, many patients discontinue within a few weeks or months of treatment.
Psychiatric Malpractice Grand Rounds: Addiction Psychiatry
February 25, 2020
James L. Knoll IV, MD, analyzes the ethical and legal duties of psychiatrists treating substance use disorders.
